Crizotinib Impurity 51 | CAS 2241658-31-9 - Request Quote
Crizotinib Impurity 51
| SZ CAT No: | SZ-C148058 |
| CAS No | 2241658-31-9 |
| Mol.F. | C13H12ClFN2O |
| Mol.Wt. | 266.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Crizotinib Impurity 51 is chemically (R)-3-(1-(2-chloro-5-fluorophenyl)ethoxy)pyridin-2-amine. Crizotinib Impurity 51 is supplied with detailed characterization data compliant with regulatory guideline. Crizotinib Impurity 51 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Crizotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2241658-31-9
Purchase 2241658-31-9
Order 2241658-31-9
Enquire 2241658-31-9
price of 2241658-31-9
2241658-31-9 Supplier
2241658-31-9 Manufacturer
2241658-31-9 Exporter
buy high quality Crizotinib Impurity 51
Purchase Crizotinib Impurity 51
Crizotinib Impurity 51 suppliers
Crizotinib Impurity 51 manufacturers
Crizotinib Impurity 51 price
Order Crizotinib Impurity 51
Enquire Crizotinib Impurity 51
Crizotinib Impurity 51 cost
Crizotinib Impurity 51 Supplier
Crizotinib Impurity 51 Distributor
Crizotinib Impurity 51 for Method Validation
Crizotinib Reference Standard
Crizotinib Impurity 51 for ANDA Filing
Crizotinib Impurity 51 for Forced Degradation Studies
Crizotinib Impurity 51 Identification Standards
Crizotinib Impurity 51 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


